• Study on the Safety and Effectiveness of EHSG-KF for Treating Deep Dermal and Full Thickness Burns in Children

    Not recruiting

    2 1 1
    Investigated Diseases:
    Italy The Netherlands
  • Study of Durvalumab, Olaparib, and Fulvestrant for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer with Specific Genetic Alterations

    Not recruiting

    2 1 1 1
    Belgium France Spain
  • Study on Naproxen Sodium and Paracetamol for Patients with Knee Osteoarthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    Poland
  • Study on the Effectiveness and Safety of Hydrocortisone Sodium Phosphate for Patients with Dry Eye and Moderate Meibomian Gland Dysfunction

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Spain
  • Study on Emapalumab for Patients with Sepsis Linked to Interferon-Gamma

    Not recruiting

    2 1 1
    Greece
  • Study on Long-term Safety and Efficacy of Elexacaftor, Tezacaftor, and Ivacaftor for Cystic Fibrosis in Patients Aged 12 Months and Older

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark Germany The Netherlands
  • Study of INBRX-109 (ozekibart) compared to placebo in adults with unresectable or metastatic chondrosarcoma – a rare bone cancer

    Not recruiting

    2 1 1
    France Germany Ireland Italy The Netherlands Spain
  • Study on Imlifidase for Patients with Severe ANCA-Associated Vasculitis and Lung Bleeding

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Germany
  • Study on the Safety of Avelumab for Patients with Solid Tumors Continuing Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Hungary Italy Poland Romania +1
  • Study on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    Belgium Czechia Finland France Germany Hungary +6

powered by